Miho Kure

31PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Nov 29, 2025
p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis.

Takeyoshi Nishiyama, Hiroshi Tazawa, Yasuo Nagai

|Oct 29, 2025
Tertiary Lymphoid Structures Are Associated with Favorable Clinical Outcomes and Negatively Correlated with Cancer-Associated Fibroblasts in Esophageal Cancer.

Tomoyoshi Kunitomo, Kazuhiro Noma, Noriyuki Nishiwaki

|Sep 24, 2025
Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancreatic cancer.

Shohei Nogi, Shunsuke Kagawa, Atsuki Taniguchi

|Oct 14, 2024
Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus.

Masashi Hashimoto, Shinji Kuroda, Nobuhiko Kanaya

|Apr 19, 2024
Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody.

Teruki Kobayashi, Kazuhiro Noma, Seitaro Nishimura

|Mar 30, 2024
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.

Masaaki Akai, Kazuhiro Noma, Takuya Kato

Pageof 6

Frequent Collaborators

18 joint publications

Toshiyuki Kunisada

11 joint publications

Shunsuke Kagawa

7 joint publications

Kazuhiro Noma

6 joint publications

Shinji Kuroda